Preparation method of vascular disease model, vascular disease model and application

By injecting prepregnant cells and hydrogel into the vascular model and culturing them in a microgravity environment, the problem of large differences between the vascular model and the internal environment of the organism is solved, and the simulation degree and analysis ability of the vascular disease model are improved. Reduced the cost of new drug research and development.

CN118995567APending Publication Date: 2024-11-22SCI RES TRAINING CENT FOR CHINESE ASTRONAUTS +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410241157.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-19
Filing Date
2024-03-04
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the prior art, the static culture environment of the vascular model is very different from the dynamic environment in the organism, resulting in a large difference between the constructed vascular model and the vascular tissue in the organism, which is not conducive to the accurate study and analysis of vascular tissues in abnormal gravity. Pathogenic mechanism of environmentally-related diseases.

Method used

Functional vascular disease model is prepared by injecting prepregnant cells and hydrogel into the vessel wall and endothelial layer, combined with dynamic flow culture, and cultivated in a microgravity environment to form a vascular disease model.

Benefits of technology

A dynamic culture environment close to the microenvironment of vascular growth in organisms was established. The constructed vascular model has little difference from the vascular tissue in organisms, which significantly improved the simulation degree of vascular disease model and helped analyze the function of blood vessels in microgravity environments and Structural changes have reduced the cost of new drug research and development and improved the success rate of drug use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995567A_ABST
    Figure CN118995567A_ABST
Patent Text Reader

Abstract

The invention provides a preparation method of a vascular disease model, the vascular disease model and application, and the preparation method of the vascular disease model comprises the following steps: injecting a vascular wall prefabricating liquid containing vascular wall prefabricating cells and hydrogel into a vascular wall preparation space, and performing vascular wall cultivation to prepare a vascular wall; injecting endothelial cell suspension containing endothelial layer prefabricated cells into a lumen channel of the blood vessel wall, and performing blood vessel endothelial layer cultivation to obtain a preliminary blood vessel model with a three-dimensional structure; dynamically adding a culture medium into a lumen channel of the blood vessel model, and performing functional cultivation to obtain a functional blood vessel model; the functional blood vessel model is cultivated in a microgravity environment with the gravity smaller than 1G, and the blood vessel disease model is prepared and obtained. The device has the technical effects that the design is reasonable, the function and structure change of the blood vessel in a microgravity environment can be accurately analyzed, and the pathogenesis of related diseases of the blood vessel can be analyzed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biological tissue engineering, and in particular relates to a preparation method of a vascular disease model, a vascular disease model and an application thereof. Background Art

[0002] Blood vessels are important tissues for transporting nutrients and metabolic impurities in organisms. In-depth research on vascular tissues is conducive to analyzing the pathogenic mechanisms of vascular-related diseases. Research shows that long-term exposure of the human body to an abnormal gravity environment will lead to a series of adaptive changes in the structure and function of blood vessels, such as symptoms of cardiovascular system disorders. The mechanism of this series of discomfort reactions is relatively complex and is still not fully understood. Establishing an artificial blood vessel model in vitro is conducive to analyzing the pathogenic mechanisms of vascular-related diseases. However, this places higher requirements on the morphological structure, functionality, and responsiveness of the vascular model to external environmental factors.

[0003] In the prior art, a standard culture plate is usually used to culture blood vessels to construct a blood vessel model, that is, artificial blood vessel tissue is placed at the bottom of the culture well of a standard culture plate; then, culture medium is added to the standard culture plate and placed in an incubator for static culture. Since the culture medium is in a static state relative to the blood vessel tissue, the blood vessel tissue can only be cultured statically, which makes the culture environment of the blood vessel tissue very different from the dynamic environment in the organism, and thus makes the constructed blood vessel model very different from the blood vessel tissue in the organism, which is not conducive to the accurate study of the blood vessel tissue, nor is it conducive to the accurate analysis of the pathogenic mechanism of diseases related to blood vessels in abnormal gravity environments. Summary of the invention

[0004] The present invention aims to solve at least one of the technical problems existing in the prior art and to provide a method for preparing a vascular disease model, a vascular disease model and a new technical solution for its application.

[0005] According to a first aspect of the present invention, there is provided a method for preparing a vascular disease model, comprising the following steps:

[0006] Preparation of vascular wall: injecting a vascular wall preparation liquid containing vascular wall preparation cells and hydrogel into the vascular wall preparation space, and preparing the vascular wall through vascular wall cultivation; the vascular wall preparation cells include at least one of smooth muscle cells, fibroblasts, and mixed cells of smooth muscle cells and fibroblasts;

[0007] Preparation of vascular endothelial layer: injecting an endothelial cell suspension containing endothelial layer prefabricated cells into the lumen channel of the vascular wall, cultivating the vascular endothelial layer, and obtaining a preliminary vascular model with a three-dimensional structure; the endothelial layer prefabricated cells are derived from vascular endothelial immortalized cells, vascular endothelial primary cells or IPSC differentiated cells;

[0008] Functional vascular cultivation: Dynamically add culture medium into the lumen of the vascular model to achieve dynamic flow culture of the vascular endothelium. Through functional cultivation, at least one of the following functions, namely, vascular contraction and relaxation function, vascular barrier function, and vascular inflammatory response function, is cultivated to obtain a functional vascular model. Dynamic flow culture or static culture can be performed by adding culture medium to the outside of the vascular wall.

[0009] Preparation of a vascular disease model: The functional vascular model is cultured in a microgravity environment with a gravity less than 1G to prepare a vascular disease model.

[0010] Optionally, in the step of preparing the vascular disease model, the functional vascular model is cultured at 35° C.-37° C. and a gravity environment of 0.05G to 0.5G for 5-21 days to prepare the vascular disease model.

[0011] Optionally, in the step of preparing the vascular wall, a vascular stent is first pre-placed in the vascular wall preparation space, and then the vascular wall preparation liquid containing vascular wall pre-formed cells and hydrogel is injected, and after vascular wall cultivation, a vascular wall with a vascular stent arranged between the walls is prepared.

[0012] Optionally, in the step of preparing the vascular wall, the vascular wall preformed solution comprises 1×10 5 Up to 1×10 7 / mL vascular wall preformed cells;

[0013] The vascular wall preformed solution is 1×10 5 Up to 1×10 7 The preformed hydrogel solution is formed by uniformly mixing the preformed vascular wall cells with the hydrogel.

[0014] Optionally, in the step of preparing the vascular wall, the vascular wall cultivation includes first culturing in a temperature environment of 35°C-37°C for 0.5h-1h, and then adding 3mL-5mL of vascular tissue culture medium to cultivate and form the vascular wall.

[0015] Optionally, in the step of preparing the vascular endothelial layer, the endothelial cell suspension contains 1×10 5 Up to 1×10 7 / ml endothelial preformed cells.

[0016] Optionally, the step of preparing the vascular endothelial layer also includes: placing the preliminary vascular model with a three-dimensional structure in a culture environment of 37° C., 5% CO 2 , and 95% humidity for 24 h to 48 h.

[0017] Optionally, in the step of preparing the vascular function, the vascular functional cultivation includes dynamically culturing the vascular endothelial layer for 2 to 4 days in a culture environment of 37° C., 5% CO 2 , and 95% humidity, thereby forming a functional vascular model.

[0018] Optionally, the method for preparing a vascular disease model further includes preparing a vascular adventitial layer.

[0019] Optionally, a vascular disease model is prepared according to the method for preparing a vascular disease model, and / or a complex disease model is prepared by further implementing a physical or chemical method on the vascular disease model.

[0020] According to a second aspect of the present invention, there is provided a vascular disease model, comprising a vascular wall and a vascular endothelial layer;

[0021] The blood vessel wall comprises blood vessel wall cells and hydrogel; a vascular stent is arranged between the walls of the blood vessel wall; the blood vessel wall cells are at least one of smooth muscle cells and fibroblasts;

[0022] The vascular endothelial layer comprises vascular endothelial cells;

[0023] The vascular model has at least one of vascular contraction and relaxation function, vascular barrier function, and vascular inflammatory response function;

[0024] The vascular model is cultured in an environment with a gravity less than 1G for 5-21 days to prepare a vascular disease model that simulates microgravity vascular injury.

[0025] Optionally, the environment with gravity less than 1G is: a temperature of 35°C-37°C and a gravity of 0.05G to 0.5G.

[0026] According to a third aspect of the present invention, there is provided a use of the vascular disease model as described in the second aspect in functional testing and / or drug analysis.

[0027] A technical effect of the present invention is:

[0028] In the embodiments of the present application, on the one hand, the method for preparing the vascular disease model can establish a dynamic vascular culture environment in vitro, which is equivalent to or similar to the vascular growth microenvironment in vivo, and the functional vascular model constructed is slightly different from the vascular tissue in vivo, which is not only conducive to the accurate analysis and research of the functional vascular model, but also conducive to the accurate preparation of the vascular disease model.

[0029] On the other hand, the preparation method of the vascular disease model cultivates a functional vascular model in a microgravity environment. The prepared vascular disease model helps to accurately analyze the changes in the function and structure of blood vessels in a microgravity environment, and then helps to analyze the pathogenic mechanism of vascular-related diseases in a microgravity environment. It significantly improves the simulation degree of the vascular disease model, has great application value in the bioengineering and pharmaceutical industries, can reduce the manpower, material and time costs of new drug research and development, and improve the success rate of medication for related diseases. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 A schematic flow chart of a method for preparing a vascular disease model according to an embodiment of the present invention;

[0031] Figure 2 A schematic diagram of the structure of a vascular stent in a method for preparing a vascular disease model according to an embodiment of the present invention;

[0032] Figure 3 This is a schematic diagram of HE staining results of an artificial blood vessel of a vascular disease model according to an embodiment of the present invention;

[0033] Figure 4 The artificial blood vessel wall Ca of the vascular disease model according to one embodiment of the present invention 2+ Schematic diagram of transient fluorescence change results.

[0034] In the figure: 1. vascular stent; 11. support ring; 12. connecting ribs. DETAILED DESCRIPTION

[0035] Various exemplary embodiments of the present application will now be described in detail with reference to the accompanying drawings. It should be noted that unless otherwise specifically stated, the relative arrangement of components and steps, numerical expressions and numerical values ​​set forth in these embodiments do not limit the scope of the present application.

[0036] The embodiments of the present application will be described in detail below, and examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain the present application, and should not be construed as limitations on the present application. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in the field without making creative work are within the scope of protection of the present application.

[0037] The term "first" or "second" in the specification and claims of this application may include one or more of the features explicitly or implicitly. In the description of this application, unless otherwise specified, "plurality" means two or more. In addition, "and / or" in the specification and claims means at least one of the connected objects, and the character " / " generally means that the objects connected before and after are in an "or" relationship.

[0038] According to a first aspect of the present invention, see Figure 1 and Figure 3 , provides a vascular model preparation method for realizing the preparation of a vascular model. The prepared vascular model has a high degree of simulation, which is helpful for accurate research on vascular tissue and accurate analysis of the pathogenic mechanism of vascular-related diseases.

[0039] According to a first aspect of the present invention, see Figure 1 , provides a method for preparing a vascular disease model, comprising the following steps:

[0040] Step S100, preparation of vascular wall: injecting a vascular wall preparation liquid containing vascular wall preparation cells and hydrogel into the vascular wall preparation space, and preparing the vascular wall through vascular wall cultivation; the vascular wall preparation cells include at least one of smooth muscle cells, fibroblasts, and mixed cells of smooth muscle cells and fibroblasts;

[0041] Step S200, preparation of the vascular endothelial layer: injecting an endothelial cell suspension containing endothelial layer prefabricated cells into the lumen channel of the vascular wall, and cultivating the vascular endothelial layer to obtain a preliminary vascular model with a three-dimensional structure; the endothelial layer prefabricated cells are derived from vascular endothelial immortalized cells, vascular endothelial primary cells or IPSC differentiated cells;

[0042] Step S300, vascular functional cultivation: dynamically adding culture medium into the lumen channel of the vascular model to achieve dynamic flow cultivation of the vascular endothelial layer, and cultivating at least one of vascular contraction and relaxation function, vascular barrier function, and vascular inflammatory response function through functional cultivation to obtain a functional vascular model;

[0043] Step S400, preparation of a vascular disease model: cultivating the vascular model in a microgravity environment with a gravity less than 1G to prepare a vascular disease model.

[0044] In the embodiments of the present application, on the one hand, the method for preparing the vascular disease model can establish a dynamic vascular culture environment in vitro, which is equivalent to or similar to the vascular growth microenvironment in vivo, and the functional vascular model constructed is slightly different from the vascular tissue in vivo, which is not only conducive to the accurate analysis and research of the functional vascular model, but also conducive to the accurate preparation of the vascular disease model.

[0045] On the other hand, the preparation method of the vascular disease model cultivates a functional vascular model in a microgravity environment. The prepared vascular disease model helps to accurately analyze the changes in the function and structure of blood vessels in a microgravity environment, and then helps to analyze the pathogenic mechanism of vascular-related diseases in a microgravity environment. It significantly improves the simulation degree of the vascular disease model, has great application value in the bioengineering and pharmaceutical industries, can reduce the manpower, material and time costs of new drug research and development, and improve the success rate of medication for related diseases.

[0046] Optionally, in the step of preparing the vascular disease model, the vascular model is cultured at 35° C.-37° C. and a gravity environment of 0.05G to 0.5G for 5-21 days to prepare the vascular disease model.

[0047] In the above embodiment, the vascular disease model prepared by culturing for 5-21 days at 35°C-37°C and a gravity environment of 0.05G to 0.5G accurately simulates the changes in vascular structure and function caused by prolonged exposure to microgravity, thereby facilitating accurate analysis of the pathogenic mechanisms of vascular-related diseases in a microgravity environment.

[0048] Optionally, in the step of preparing the vascular wall, a vascular stent is first pre-placed in the vascular wall preparation space, and then the vascular wall preparation liquid containing vascular wall pre-formed cells and hydrogel is injected, and after vascular wall cultivation, a vascular wall with a vascular stent arranged between the walls is prepared.

[0049] In the above embodiment, the vascular stent disposed between the walls of the blood vessel wall can significantly improve the strength of the vascular disease model, so that the vascular disease model has a higher burst strength.

[0050] In a specific embodiment, the vascular stent is a tubular mesh structure. Figure 2 The vascular stent 1 includes a support ring 11 and a connecting rib 12, and both the support ring 11 and the connecting rib 12 are wavy; a plurality of the support rings 11 are distributed at intervals along the axial direction of the vascular stent 1; at least one connecting rib 12 is connected between two adjacent support rings 11.

[0051] In the above embodiment, on the one hand, the structure of the vascular stent 1 is relatively stable, which is convenient for supporting the vascular disease model; on the other hand, the tubular mesh structure of the vascular stent does not affect the preparation of the vascular endothelium and the cultivation of vascular functionality, which is conducive to obtaining a functional vascular model and a vascular disease model with a higher degree of simulation.

[0052] Optionally, in the step of preparing the vascular wall, the vascular wall preformed solution comprises 1×10 5 Up to 1×107 / mL vascular wall preformed cells;

[0053] The vascular wall preformed solution is 1×10 5 Up to 1×10 7 The preformed hydrogel solution is formed by uniformly mixing the preformed vascular wall cells with the hydrogel.

[0054] In the above embodiment, the use of a hydrogel preformed liquid formed by uniformly mixing an appropriate number of vascular wall preformed cells with the hydrogel is conducive to accurately preparing a vascular wall with a certain elasticity, thereby ensuring the simulation of the vascular wall.

[0055] Optionally, in the step of preparing the vascular wall, the vascular wall cultivation includes first culturing in a temperature environment of 35°C-37°C for 0.5h-1h, and then adding 3mL-5mL of vascular tissue culture medium to cultivate and form the vascular wall.

[0056] In the above embodiment, the culture medium is first placed in a 35°C-37°C temperature environment for 0.5h-1h, which is helpful for the cultivation of the vascular wall and improves the efficiency of the vascular wall cultivation. Then, 3mL-5mL of vascular tissue culture medium is added, which is helpful for cultivating and forming a vascular wall with a higher degree of simulation.

[0057] Optionally, in the step of preparing the vascular endothelial layer, the endothelial cell suspension contains 1×10 5 Up to 1×10 7 / ml endothelial preformed cells.

[0058] In the above embodiment, in the step of preparing the vascular endothelial layer, the endothelial cell suspension contains an appropriate number of preformed endothelial layer cells, which helps the vascular endothelial layer to form a smooth surface to facilitate blood flow.

[0059] Optionally, the step of preparing the vascular endothelial layer also includes: placing the preliminary vascular model with a three-dimensional structure in a culture environment of 37° C., 5% CO 2 , and 95% humidity for 24 hours to 48 hours.

[0060] In the above embodiment, the vascular layer is prepared in a suitable environment, which ensures that the prepared vascular endothelial layer has functions such as vasoconstriction and vasodilation, so that the prepared vascular endothelial layer has a high degree of simulation.

[0061] Optionally, in the step of preparing the vascular function, the vascular function cultivation includes dynamically culturing the vascular endothelial layer for 2 to 4 days in a culture environment at 37° C., 5% CO 2 , and 95% humidity, thereby forming a functional vascular model.

[0062] In the above embodiment, it is helpful to form a functional blood vessel model. Moreover, by culturing with dynamic flow for 2-4 days, it is ensured that the culture environment of the blood vessel model is slightly different from the blood vessel tissue in the body, thereby improving the simulation of the functional blood vessel model.

[0063] Optionally, the method for preparing a vascular disease model further includes preparing a vascular adventitia layer, which helps to form a structurally complete vascular disease model, ensures the integrity and simulation of the vascular model, helps to more accurately analyze the changes in the function and structure of the blood vessels in a microgravity environment, and is also conducive to functional testing of the vascular disease model.

[0064] In a specific embodiment, the preparation of the adventitia layer of the vascular comprises: first, in a sterile environment, taking 1×10 4 -1×10 6 The cells are mixed evenly with the hydrogel to form a hydrogel mixture, and the hydrogel mixture is injected into the vascular tissue preparation chip, placed in a 35°C-37°C incubator for incubation, and after 0.5h-1h, 5mL-10mL of vascular tissue culture medium is added to culture to form a vascular adventitia layer. Wherein, the cells are fibroblasts. The hydrogel includes matrix glue, or a single or mixed natural polymer material, a synthetic polymer material, and the gelation method of the hydrogel includes light curing, temperature curing, pH curing, etc. Then, the vascular tissue preparation chip is placed in an incubator at 37°C, 5% CO2, and 95% humidity for static culture for 24h to 48h, and the vascular endothelial layer is prepared after the adventitia layer of the vascular tissue is formed.

[0065] Optionally, a vascular disease model prepared according to the preparation method of the vascular disease model, and / or a complex disease model prepared by further implementing a physical or chemical method on the vascular disease model. For example, after the vascular disease model is successfully prepared, a certain concentration of TNF-α, monocytes or macrophages and other inflammatory stimulating factors are used to stimulate the vascular endothelium and vascular wall, and then a vascular inflammation model, an atherosclerosis model and other vascular complex disease models are constructed, which is helpful for accurate analysis of vascular diseases.

[0066] In the above-mentioned embodiment, the prepared vascular disease model can accurately simulate a series of adaptive changes in the structure and function of blood vessels caused by long-term exposure of the human body to an abnormal gravity environment, which is beneficial for studying the mechanism of the human body's discomfort reaction in an abnormal gravity environment through the vascular disease model, thereby helping to analyze the pathogenic mechanism of vascular-related diseases in a microgravity environment.

[0067] Furthermore, complex disease models prepared by further implementing physical or chemical methods on vascular disease models have great application value in the bioengineering and pharmaceutical industries, which can reduce the manpower, material and time costs of new drug research and development and improve the success rate of medication for related diseases. At the same time, the vascular disease model has high stability under the support of vascular stents, can withstand high impact in some scenarios, greatly improving the tolerance of external forces, and can also simulate dynamic environments to cultivate blood vessels under conditions such as microgravity and strong electric fields, thereby improving the degree of simulation of blood vessels.

[0068] According to a second aspect of the present invention, a vascular disease model is provided, comprising a vascular wall and a vascular endothelial layer; the vascular wall comprises vascular wall cells and a hydrogel; a vascular stent is arranged between the walls of the vascular wall; the vascular wall cells are at least one of smooth muscle cells and fibroblasts;

[0069] The vascular endothelial layer comprises vascular endothelial cells;

[0070] The vascular model has at least one of vascular contraction and relaxation function, vascular barrier function, and vascular inflammatory response function;

[0071] The vascular model is cultured for 5-21 days in an environment with a gravity less than 1G to prepare a vascular disease model simulating microgravity vascular injury. For example, microgravity vascular injury includes but is not limited to vascular injury caused by poor orthostatic tolerance, hypovolemia, hypotension, etc.

[0072] In the above-mentioned embodiment, the prepared vascular disease model simulating microgravity vascular injury can accurately study the structural and functional changes of vascular tissue in a microgravity environment, thereby facilitating accurate analysis of the pathogenic mechanism of vascular-related diseases.

[0073] Optionally, the environment with gravity less than 1G is: a temperature of 35°C-37°C and a gravity of 0.05G to 0.5G.

[0074] In the above-mentioned embodiment, the vascular disease model prepared in a gravity environment of 35°C-37°C and 0.05G to 0.5G accurately simulates the changes in vascular structure and function caused by prolonged exposure to microgravity, thereby facilitating accurate analysis of the pathogenic mechanisms of vascular-related diseases in a microgravity environment.

[0075] According to a third aspect of the present invention, there is provided a use of the vascular disease model as described in the second aspect in functional testing and / or drug analysis.

[0076] In the above-mentioned implementation manner, functional testing and / or drug analysis of the vascular disease model has great application value to the bioengineering and pharmaceutical industries, can reduce the manpower, material and time costs of new drug research and development, and improve the success rate of medication for related diseases. It has great application value to the bioengineering and pharmaceutical industries, can reduce the manpower, material and time costs of new drug research and development, and improve the success rate of medication for related diseases.

[0077] In a specific embodiment, the use of the vascular disease model in functional testing and / or drug analysis includes:

[0078] First, the vascular disease model in the vascular tissue culture chip is subjected to an irritation test. Then, after incubation for a preset time, some of the liquid in the vascular tissue culture chip is removed for detection and analysis. Next, the changes in the vascular disease model after the irritation test are directly observed under a microscope and photographed or recorded by video. Finally, the vascular disease model in the vascular tissue culture chip is removed, and the vascular disease model is sliced, stained, and tested.

[0079] In the above-mentioned embodiment, multiple tests can be performed on the blood vessel model as required, and the test results are relatively accurate.

[0080] In a specific embodiment, the application of the vascular disease model in drug analysis includes drug stimulation of the vascular disease model, that is, using drugs to perform drug stimulation tests on the vascular disease model. Drug stimulation tests are simple to operate, the test results are relatively reliable, and can reduce the manpower, material and time costs of new drug research and development, and improve the success rate of medication for related diseases.

[0081] Optionally, the drug irritation test also includes: fluorescently labeling the drug with fluorescent particles, and determining the location of drug penetration based on the fluorescent labeling. This can accurately analyze the effect of the drug on the vascular model, and also helps to analyze the location of drug penetration, which helps to improve the success rate of medication for related diseases.

[0082] Furthermore, after the drug is added, the inflammatory protein index of the vascular disease model is detected. If the inflammatory protein index increases, the drug effect is good; otherwise, the drug effect is not good. In this way, whether the vascular disease model has a barrier function is better detected.

[0083] In the above implementation, the therapeutic effect of the drug can be accurately obtained, the human, material and time costs of new drug research and development can be reduced, and it has great application value to the bioengineering and pharmaceutical industries.

[0084] Optionally, the application of the vascular disease model in functional testing includes physically stimulating the vascular disease model, that is, placing a vascular tissue culture chip containing the vascular disease model in a microgravity simulation device, and dynamically culturing the vascular disease model in the vascular tissue culture chip, and testing the vascular disease model at different culture cycles. The change in physical conditions can be used to detect the impact on vascular tissue structure and function.

[0085] For example, during the culture period, vascular disease models cultured for different days can be extracted for testing and analysis according to experimental needs. Figure 3 As shown, the HE staining result of the artificial blood vessel can be seen in the local magnified area of ​​the figure, which can reflect the impact of gravity changes on the vascular structure and morphology.

[0086] Optionally, the application of the vascular disease model in functional testing includes performing a reagent irritation test on the vascular disease model. The reagent irritation test includes:

[0087] First, Ca was injected into the culture chamber of the vascular tissue culture chip. 2+ After adding the indicator solution, the culture chamber was sealed and the vascular tissue culture chip was placed in a 37°C incubator for 1 h-2 h to measure the Ca content in the vascular disease model. 2+ Perform fluorescent staining;

[0088] Then, the vascular tissue culture chip is used to inject vasoconstriction / dilation stimulating reagents into the lumen of the vascular model and incubate for a preset time; the contraction / dilation changes of the vascular model are observed under a white light microscope, or the Ca2+ of the cells in the vascular model is observed under a fluorescence microscope. 2+ Instantaneous changes.

[0089] As attached Figure 4 As shown, the arrows in the right figure indicate the injection of vasoconstriction / relaxation stimulating reagents, #1-#7 correspond to different positions of the blood vessels in the left figure, and the right figure shows the change in fluorescence intensity of #1-#7 over time after the addition of vasoconstriction / relaxation stimulating reagents, which can reflect the effect of the stimulating reagents.

[0090] In the above embodiment, the irritant agent detection on the vascular disease model is helpful to prove whether the vascular disease model has contraction and relaxation functions, and the operation is simple and the detection results are easy to observe.

[0091] It is to be understood that the above embodiments are merely exemplary embodiments used to illustrate the principles of the present invention, but the present invention is not limited thereto. For those of ordinary skill in the art, various modifications and improvements can be made without departing from the spirit and essence of the present invention, and these modifications and improvements are also considered to be within the scope of protection of the present invention.

Claims

1. A method for preparing a vascular disease model, characterized in that: The steps include: Preparation of vascular wall: injecting a vascular wall preparation liquid containing vascular wall preparation cells and hydrogel into the vascular wall preparation space, and preparing the vascular wall through vascular wall cultivation; the vascular wall preparation cells include at least one of smooth muscle cells, fibroblasts, and mixed cells of smooth muscle cells and fibroblasts; Preparation of vascular endothelial layer: injecting an endothelial cell suspension containing endothelial layer prefabricated cells into the lumen channel of the vascular wall, cultivating the vascular endothelial layer, and obtaining a preliminary vascular model with a three-dimensional structure; the endothelial layer prefabricated cells are derived from vascular endothelial immortalized cells, vascular endothelial primary cells or IPSC differentiated cells; Functional vascular cultivation: Dynamically add culture medium into the lumen of the vascular model to achieve dynamic flow cultivation of the vascular endothelial layer. Through functional cultivation, at least one of the following functions, including vascular contraction and relaxation function, vascular barrier function, and vascular inflammatory response function, is cultivated to obtain a functional vascular model. Preparation of a vascular disease model: The functional vascular model is cultured in a microgravity environment with a gravity less than 1G to prepare a vascular disease model.

2. The method for preparing a vascular disease model according to claim 1, characterized in that In the step of preparing the vascular disease model, the functional vascular model is cultured at 35°C-37°C and a gravity environment of 0.05G to 0.5G for 5-21 days to prepare a vascular disease model.

3. The method for preparing a vascular disease model according to claim 1, characterized in that In the step of preparing the vascular wall, a vascular stent is first pre-placed in the vascular wall preparation space, and then the vascular wall preparation liquid containing vascular wall pre-formed cells and hydrogel is injected. After the vascular wall is cultivated, a vascular wall with a vascular stent arranged between the walls is prepared.

4. A method for preparing a vascular disease model according to any one of claims 1 to 3, characterized in that In the step of preparing the vascular wall, the vascular wall preformed solution includes 1×10 5 Up to 1×10 7 / mL vascular wall preformed cells; The vascular wall preformed solution is 1×10 5 Up to 1×10 7 The preformed hydrogel solution is formed by uniformly mixing the preformed vascular wall cells with the hydrogel.

5. The method for preparing a vascular disease model according to claim 4, characterized in that In the preparation step of the vascular wall, the vascular wall cultivation includes first placing it in a temperature environment of 35°C-37°C for 0.5h-1h, and then adding 3mL-5mL of vascular tissue culture medium to cultivate and form the vascular wall.

6. A method for preparing a vascular disease model according to any one of claims 1 to 3, characterized in that In the step of preparing the vascular endothelial layer, the endothelial cell suspension contains 1×10 5 Up to 1×10 7 / ml endothelial preformed cells.

7. The method for preparing a vascular disease model according to claim 6, characterized in that The preparation step of the vascular endothelial layer also includes: placing the preliminary vascular model with a three-dimensional structure in a culture environment of 37° C., 5% CO2, and 95% humidity for 24 hours to 48 hours.

8. A method for preparing a vascular disease model according to any one of claims 1 to 3, characterized in that In the preparation step of the vascular function, the vascular functional cultivation includes dynamically culturing the vascular endothelial layer for 2 to 4 days in a culture environment of 37°C, 5% CO2, and 95% humidity, thereby forming a functional vascular model.

9. A method for preparing a vascular disease model according to any one of claims 1 to 3, characterized in that , also including the preparation of the vascular adventitia layer.

10. A vascular disease model prepared according to the method for preparing a vascular disease model according to claims 1-9, and / or a complex disease model prepared by further implementing a physical or chemical method on the vascular disease model.

11. A vascular disease model, comprising a vascular wall and a vascular endothelial layer; characterized in that: The blood vessel wall comprises blood vessel wall cells and hydrogel; a vascular stent is arranged between the walls of the blood vessel wall; the blood vessel wall cells are at least one of smooth muscle cells and fibroblasts; The vascular endothelial layer comprises vascular endothelial cells; The vascular model has at least one of vascular contraction and relaxation function, vascular barrier function, and vascular inflammatory response function; The vascular model is cultured in an environment with a gravity less than 1G for 5-21 days to prepare a vascular disease model that simulates microgravity vascular injury.

12. A vascular disease model according to claim 11, characterized in that: The environment where the gravity is less than 1G is: a temperature of 35°C-37°C, and a gravity of 0.05G to 0.5G.

13. Use of the vascular disease model according to any one of claims 1 to 12 in functional testing and / or drug analysis.